Every SEC Form 3/4/5 on record for this filer (CIK 1643067) — 2 issuers, 16 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ACET | Adicet Bio, Inc. | Chief Technology Officer | 2020-10-29 → 2026-03-27 | 21 | −$117,841 |
| OPXA | Opexa Therapeutics, Inc. | Chief Scientific Officer · lapsed | 2015-11-03 → 2016-05-18 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ACET | 2023-02-15 | Sell | 4,533 | $7.57 | $34,315 | 66,568 |
| ACET | 2023-02-10 | Sell | 10,467 | $7.98 | $83,527 | 71,101 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.